Modelled cost-effectiveness of high cut-off haemodialysis compared to standard haemodialysis in the management of myeloma kidney

By Grima Daniel T.   Airia Parisa   Attard Cheryl   Hutchison Colin A.  

Current Medical Research and Opinion, Vol. 27, Iss. 2, 2011-02 ,pp. : 383-391

Informa Healthcare

Access to resources Recommend Favorite

Baseline HCV‐RNA levels in genotype 1 chronic hepatitis C patients: The role of different cut‐off points

By  

HEPATOLOGY, Vol. 64, Iss. 4, 2016-10 ,pp. : 1385-1386

John Wiley & Sons Inc

Access to resources Recommend Favorite

The absolute percent deviation of IGHV mutation rather than a 98% cut‐off predicts survival of chronic lymphocytic leukaemia patients treated with fludarabine, cyclophosphamide and rituximab

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 180, Iss. 1, 2018-01 ,pp. : 33-40

John Wiley & Sons Inc

Access to resources Recommend Favorite

The absolute percent deviation of IGHV mutation rather than a 98% cut‐off predicts survival of chronic lymphocytic leukaemia patients treated with fludarabine, cyclophosphamide and rituximab

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 180, Iss. 1, 2018-01 ,pp. : 7-8

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bortezomib‐based therapy combined with high cut‐off hemodialysis is highly effective in newly diagnosed multiple myeloma patients with severe renal impairment

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 7, 2015-07 ,pp. : 647-652

John Wiley & Sons Inc

Access to resources Recommend Favorite